In accordance with a previous study, we observed an anti-tumor immune response upon mRNA Galsome vaccination, as evidenced by an increase in iNKT cells and tumor-specific CD8+ T cells in systemic organs and tumor 11. The gene discussed is CD8A; the disease is neoplasm.